• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年骨折后骨质疏松症诊断与治疗的遗漏:一种可避免的治疗失误?]

[Omission of osteoporosis diagnostics and therapy after fractures in the elderly : an avoidable treatment error?].

作者信息

Neuerburg C, Heberer K, Heberer J

机构信息

Klinik für Allgemeine, Unfall-, Hand- und Plastische Chirurgie, Osteologisches Schwerpunktzentrum (DVO), Klinikum der Ludwig-Maximilians-Universität München, Campus Innenstadt, Nußbaumstr. 20, 80336, München, Deutschland.

Rechtsanwaltskanzlei Dr. Heberer & Kollegen, Paul-Hösch-Straße 25a, 81243, München, Deutschland.

出版信息

Unfallchirurg. 2015 Nov;118(11):938-43. doi: 10.1007/s00113-015-0072-1.

DOI:10.1007/s00113-015-0072-1
PMID:26423918
Abstract

Through a more consistent diagnostics and treatment of osteoporosis, subsequent fractures and associated complications could be reduced in aged patients. Whereas anticoagulants are now standard in the treatment of fractures of the lower extremities to prevent thromboembolic complications in orthopedic surgery and an omission of anticoagulation can be regarded as medical malpractice, the management of osteoporosis following such fractures is very frequently disregarded. Although guidelines for osteoporosis, such as those from the governing body on osteology (Dachverband Osteologie, DVO) from 2014 are not legally binding as such, the breach of this standard of care can constitute a breach of medical obligation by the physician. The omission of osteoporosis diagnostics and initiation of treatment despite appropriate findings after fractures in aged patients, could represent a diagnostic assessment error and severe malpractice in the legal sense. In this case, evidence of a serious malpractice could be associated with civil, criminal and professional claims which could be linked with relevant legal consequences. Regardless of the legal consequences for omission of osteoporosis management following multiple fractures in aged patients, the management of osteoporosis should be an integral component in the treatment of these patients in the future.

摘要

通过对骨质疏松症进行更一致的诊断和治疗,可以减少老年患者随后发生的骨折及相关并发症。虽然抗凝剂目前是治疗下肢骨折的标准用药,以预防骨科手术中的血栓栓塞并发症,且不进行抗凝治疗可被视为医疗事故,但此类骨折后骨质疏松症的管理却常常被忽视。尽管骨质疏松症指南,如2014年骨科学 governing body(德国骨科学会,DVO)发布的指南本身并无法律约束力,但违反这一护理标准可能构成医生违反医疗义务。老年患者骨折后尽管有适当的检查结果却未进行骨质疏松症诊断及开始治疗,在法律意义上可能代表诊断评估错误和严重的医疗事故。在这种情况下,严重医疗事故的证据可能会引发民事、刑事和职业索赔,并可能带来相关法律后果。无论老年患者多次骨折后未进行骨质疏松症管理会带来何种法律后果,骨质疏松症的管理在未来都应成为这些患者治疗的一个组成部分。

相似文献

1
[Omission of osteoporosis diagnostics and therapy after fractures in the elderly : an avoidable treatment error?].[老年骨折后骨质疏松症诊断与治疗的遗漏:一种可避免的治疗失误?]
Unfallchirurg. 2015 Nov;118(11):938-43. doi: 10.1007/s00113-015-0072-1.
2
[New DVO guideline for osteoporosis management 2014 and its importance for trauma surgeons].[2014年骨质疏松症管理新的DVO指南及其对创伤外科医生的重要性]
Unfallchirurg. 2015 Nov;118(11):905-12. doi: 10.1007/s00113-015-0070-3.
3
[Identification, diagnostics and guideline conform therapy of osteoporosis (DVO) in trauma patients : a treatment algorithm].创伤患者骨质疏松症(DVO)的识别、诊断及指南遵循治疗:一种治疗算法
Unfallchirurg. 2015 Nov;118(11):913-24. doi: 10.1007/s00113-015-0071-2.
4
[Secondary fracture prevention/Update osteoporosis guidelines 2023 of the Umbrella Organization Osteology].[二级骨折预防/骨科学伞状组织2023年骨质疏松症指南更新]
Unfallchirurgie (Heidelb). 2024 Apr;127(4):283-289. doi: 10.1007/s00113-024-01415-3. Epub 2024 Mar 25.
5
[Osteoporosis: Diagnostics and Therapy According to the German Guidelines].[骨质疏松症:根据德国指南的诊断与治疗]
Z Orthop Unfall. 2016 Jun;154(3):237-44. doi: 10.1055/s-0041-110813. Epub 2016 Feb 4.
6
[Osteoporosis].
Unfallchirurg. 2015 Nov;118(11):904. doi: 10.1007/s00113-015-0076-x.
7
[Prevalence and management of osteoporosis in trauma surgery. Implementation of national guidelines during inpatient fracture treatment].[创伤外科中骨质疏松症的患病率与管理。住院骨折治疗期间国家指南的实施情况]
Unfallchirurg. 2015 Feb;118(2):138-45. doi: 10.1007/s00113-013-2500-4.
8
[New strategies for exercise training in osteoporosis].[骨质疏松症运动训练的新策略]
Unfallchirurg. 2015 Nov;118(11):933-7. doi: 10.1007/s00113-015-0080-1.
9
[Osteoporosis - Pain relief first!].[骨质疏松症——首先缓解疼痛!]
MMW Fortschr Med. 2015 Sep 24;157(16):59-62. doi: 10.1007/s15006-015-3541-0.
10
Diagnosis and Treatment of Osteoporosis: What Orthopaedic Surgeons Need to Know.骨质疏松症的诊断与治疗:骨科医生须知。
J Am Acad Orthop Surg. 2019 Oct 15;27(20):e902-e912. doi: 10.5435/JAAOS-D-18-00600.

引用本文的文献

1
[Osteoporosis-risk evaluation and case finding].[骨质疏松症风险评估与病例发现]
Orthopadie (Heidelb). 2023 Oct;52(10):787-792. doi: 10.1007/s00132-023-04431-0. Epub 2023 Aug 23.
2
[Interdisciplinary management in geriatric trauma surgery : Results of a survey in Austria].[老年创伤外科的跨学科管理:奥地利一项调查的结果]
Unfallchirurg. 2017 Sep;120(9):761-768. doi: 10.1007/s00113-016-0231-z.

本文引用的文献

1
Goal-directed treatment of osteoporosis in Europe.欧洲骨质疏松症的目标导向治疗
Osteoporos Int. 2014 Nov;25(11):2533-43. doi: 10.1007/s00198-014-2787-1. Epub 2014 Sep 9.
2
Antithrombotic prophylaxis in major orthopaedic surgery: an historical overview and update of current recommendations.骨科大手术后的抗血栓预防:历史概述及当前建议的更新。
Int Orthop. 2014 Jan;38(1):169-75. doi: 10.1007/s00264-013-2134-8. Epub 2013 Oct 11.
3
Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA).
欧盟的骨质疏松症:医疗管理、流行病学和经济负担。这份报告是与国际骨质疏松基金会(IOF)和欧洲制药工业协会联合会(EFPIA)合作编写的。
Arch Osteoporos. 2013;8(1):136. doi: 10.1007/s11657-013-0136-1. Epub 2013 Oct 11.
4
Teriparatide treatment of severe osteoporosis reduces the risk of vertebral fractures compared with standard care in routine clinical practice.特立帕肽治疗严重骨质疏松症可降低常规临床实践中与标准护理相比的椎体骨折风险。
Calcif Tissue Int. 2014 Feb;94(2):176-82. doi: 10.1007/s00223-013-9788-5. Epub 2013 Sep 13.
5
Denosumab reduces the risk of osteoporotic fractures in postmenopausal women, particularly in those with moderate to high fracture risk as assessed with FRAX.地舒单抗可降低绝经后妇女发生骨质疏松性骨折的风险,尤其是在使用 FRAX 评估为中至高骨折风险的患者中。
J Bone Miner Res. 2012 Jul;27(7):1480-6. doi: 10.1002/jbmr.1606.
6
Long-term functional outcome in geriatric hip fracture patients.老年髋部骨折患者的长期功能预后。
Arch Orthop Trauma Surg. 2011 Oct;131(10):1435-44. doi: 10.1007/s00402-011-1313-6. Epub 2011 Apr 27.
7
Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey.荷兰骨科血栓预防:一项5年随访调查。
Acta Orthop. 2009 Feb;80(1):109-12. doi: 10.1080/17453670902807441.
8
Zoledronic acid and clinical fractures and mortality after hip fracture.唑来膦酸与髋部骨折后的临床骨折及死亡率
N Engl J Med. 2007 Nov 1;357(18):1799-809. doi: 10.1056/NEJMoa074941. Epub 2007 Sep 17.
9
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.每年一次唑来膦酸用于治疗绝经后骨质疏松症。
N Engl J Med. 2007 May 3;356(18):1809-22. doi: 10.1056/NEJMoa067312.
10
Epidemiology, treatment and costs of osteoporosis in Germany--the BoneEVA Study.德国骨质疏松症的流行病学、治疗及成本——骨EVA研究
Osteoporos Int. 2007 Jan;18(1):77-84. doi: 10.1007/s00198-006-0206-y. Epub 2006 Sep 19.